Physician And Patient Barriers To Radiotherapy Service Access: Treatment Referral Implications

References

• Crook JM, Gomez-Iturriaga A, Wallace K, et al. Comparison of health-related quality of life 5 years after SPIRIT: surgical prostatectomy versus interstitial radiation intervention trial. J Clin Oncol. 2011;29:362–368. doi:10.1200/JCO.2010.31.730521149658
   PubMed Web of Science ®Google Scholar
• Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535–540. doi:10.1016/S0140-6736(97)02250-29284774
   PubMed Web of Science ®Google Scholar
• Pignon JP, le Maître A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14. doi:10.1016/j.radonc.2009.04.01419446902
   PubMed Web of Science ®Google Scholar
• Lancia A, Ingrosso G, Carosi A, et al. Oligometastatic cancer in elderly patients: the “blitzkrieg” radiotherapy approach. Aging Clin Exp Res. 2019;31:109–114. doi:10.1007/s40520-018-0937-629594874
   PubMed Web of Science ®Google Scholar
• Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393:2051–2058. doi:10.1016/S0140-6736(18)32487-530982687
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama. 2010;303:1070–1076. doi:10.1001/jama.2010.26120233825
   PubMed Web of Science ®Google Scholar
• Lancia A, Ingrosso G, Carosi A, et al. Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis. Acta Oncol. 2017;56:1621–1625. doi:10.1080/0284186X.2017.134638328820285
   PubMed Web of Science ®Google Scholar
• Warren JL, Yabroff KR, Meekins A, et al. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888–897. doi:10.1093/jnci/djn17518544740
   PubMed Web of Science ®Google Scholar
• Barton MB, Jacob S, Shafiq J, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol. 2014;112:140–144. doi:10.1016/j.radonc.2014.03.02424833561
   PubMed Web of Science ®Google Scholar
• Borras JM, Lievens Y, Dunscombe P, et al. The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol. 2015;116:38–44. doi:10.1016/j.radonc.2015.04.01825981052
   PubMed Web of Science ®Google Scholar
• Borras JM, Lievens Y, Grau C, et al. The need for radiotherapy in Europe in 2020: not only data but also a cancer plan. Acta Oncol. 2015;54:1268–1274. doi:10.3109/0284186X.2015.106213926213310
   PubMed Web of Science ®Google Scholar
• Lievens Y, De Schutter H, Stellamans K, et al. Radiotherapy access in Belgium: how far are we from evidence-based utilisation? Eur J Cancer. 2017;84:102–113. doi:10.1016/j.ejca.2017.07.01128802187
   PubMed Web of Science ®Google Scholar
• Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19:127–140. doi:10.1097/00005650-198102000-000017206846
   PubMed Web of Science ®Google Scholar
• Turnock B. Public Health: What It Is and How It Works. 4th ed. Sudbury MA: Jones and Bartlett Publishers; 2009.
   Google Scholar
• Sundaresan P, King MT, Stockler MR, et al. Barriers to radiotherapy utilisation in New South Wales Australia: health professionals’ perceptions of impacting factors. J Med Imaging Radiat Oncol. 2015;59:535–541. doi:10.1111/1754-9485.1233426076378
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.19622511
   PubMed Web of Science ®Google Scholar
• Szumacher E, Barbera L, Barnes E, et al. Improving access to radiotherapy services in the Simcoe-Muskoka region of Ontario: needs assessment study. Int J Radiat Oncol Biol Phys. 2007;69:S557.
   Web of Science ®Google Scholar
• Samant RS, Fitzgibbon E, Meng J, et al. Barriers to palliative radiotherapy referral: a Canadian perspective. Acta Oncol. 2007;46:659–663. doi:10.1080/0284186060097900517562442
   PubMed Web of Science ®Google Scholar
• Gillan C, Briggs K, Goytisolo Pazos A, et al. Barriers to accessing radiation therapy in Canada: a systematic review. Radiat Oncol. 2012;7:167.23062109
   PubMed Web of Science ®Google Scholar
• Halkett GK, Jiwa M, Meng X, et al. Referring advanced cancer patients for palliative treatment: a national structured vignette survey of Australian GPs. Fam Pract. 2014;31:60–70. doi:10.1093/fampra/cmt06824277383
   PubMed Web of Science ®Google Scholar
• Samant R, Fitzgibbon E, Meng J, et al. Family physicians’ perspectives regarding palliative radiotherapy. Radiother Oncol. 2006;78:101–106. doi:10.1016/j.radonc.2005.11.00816330118
   PubMed Web of Science ®Google Scholar
• Staffurth J; Radiotherapy Development Board. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol. 2010;22:643–657.
   PubMed Web of Science ®Google Scholar
• Fodor A, Lancia A, Ceci F, et al. Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row. World J Urol. 2018 Epub ahead of print. doi:10.1007/s00345-018-2322-7
   PubMed Web of Science ®Google Scholar
• Dawson LA, Ménard C. Imaging in radiation oncology: a perspective. Oncologist. 2010;15:338–349. doi:10.1634/theoncologist.2009-S10620413639
   PubMed Web of Science ®Google Scholar
• McCloskey SA, Tao ML, Rose CM, et al. National survey of perspectives of palliative radiation therapy: role, barriers, and needs. Cancer J. 2007;13:130–137. doi:10.1097/PPO.0b013e31804675d417476142
   PubMed Web of Science ®Google Scholar
• Boxer MM, Vinod SK, Shafiq J, et al. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer. 2011;117:5112–5120. doi:10.1002/cncr.2614921523766
   PubMed Web of Science ®Google Scholar
• Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56–72. doi:10.1016/j.ctrv.2015.11.00726643552
   PubMed Web of Science ®Google Scholar
• Atwell D, Vignarajah DD, Chan BA, et al. Referral rates to multidisciplinary team meetings: is there disparity between tumour streams? J Med Imaging Radiat Oncol. 2019;63:378–382. doi:10.1111/1754-9485.1285130623607
   PubMed Web of Science ®Google Scholar
• Johnston GM, Boyd CJ, Joseph P, et al. Variation in delivery of palliative radiotherapy to persons dying of cancer in Nova Scotia, 1994 to 1998. J Clin Oncol. 2001;19:3323–3332. doi:10.1200/JCO.2001.19.14.332311454879
   PubMed Web of Science ®Google Scholar
• Aarts MJ, van der Aa MA, Coebergh JW, et al. Reduction of socioeconomic inequality in cancer incidence in the South of the Netherlands during 1996–2008. Eur J Cancer. 2010;46:2633–2646. doi:10.1016/j.ejca.2010.07.03920843492
   PubMed Web of Science ®Google Scholar
• Stracci F, Bianconi F, Lupi C, et al. Spatial barriers impact upon appropriate delivery of radiotherapy in breast cancer patients. Cancer Med. 2018;7:370–379. doi:10.1002/cam4.130429356463
   PubMed Web of Science ®Google Scholar
• Wong J, Xu B, Yeung HN, et al. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014;90:224–230. doi:10.1016/j.ijrobp.2014.03.05025195994
   PubMed Web of Science ®Google Scholar
• Tyldesley S, Zhang-Salomons J, Groome PA, et al. Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 2000;47:469–480. doi:10.1016/s0360-3016(00)00440-510802375
   PubMed Web of Science ®Google Scholar
• Tyldesley S, Roques TW, Erridge S. General practitioner assessment of stage and performance status in lung cancer patients at a population level: implications for prognosis and radiotherapy needs analyses. Lung Cancer. 2007;57:381–388. doi:10.1016/j.lungcan.2007.03.02417485136
   PubMed Web of Science ®Google Scholar
• Lavergne MR, Johnston GM, Gao J, et al. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med. 2011;25:101–110. doi:10.1177/026921631038490020937613
   PubMed Web of Science ®Google Scholar
• Hayman JA, Abrahamse PH, Lakhani I, et al. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;69:1001–1007. doi:10.1016/j.ijrobp.2007.04.05917689029
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619. doi:10.1016/0895-4356(92)90133-81607900
   PubMed Web of Science ®Google Scholar
• Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258–1267. doi:10.1016/s0895-4356(00)00256-011146273
   PubMed Web of Science ®Google Scholar
• Potosky AL, Merrill RM, Riley GF, et al. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res. 1999;34:525–546.10357289
   PubMed Web of Science ®Google Scholar
• Riley GF, Potosky AL, Klabunde CN, et al. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA. 1999;281:720–726. doi:10.1001/jama.281.8.72010052442
   PubMed Web of Science ®Google Scholar
• Puts MT, Monette J, Girre V, et al. Characteristics of older newly diagnosed cancer patients refusing cancer treatments. Support Care Cancer. 2010;18:969–974. doi:10.1007/s00520-010-0883-020419496
   PubMed Web of Science ®Google Scholar
• Huang J, Zhou S, Groome P, et al. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001;19:137–144. doi:10.1200/JCO.2001.19.1.13711134206
   PubMed Web of Science ®Google Scholar
• Shaaban SG, Verma V, Choi JI, et al. Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States. Clin Lung Cancer. 2018;19:e685–e692. doi:10.1016/j.cllc.2018.04.01929803576
   PubMed Web of Science ®Google Scholar
• Fortin B. Goldberg MS, Mayo NE et al. Waiting time for radiation therapy in breast cancer patients in Quebec from 1992 to 1998: a study of surgically treated breast cancer patients in Quebec documents and helps to explain increased waiting times for radiation therapy.Healthcare Policy. 2006;1:152–167.19305663
   PubMedGoogle Scholar